Nuevos farmacos en insuficiencia cardíaca

Translated title of the contribution: New pharmacological agents in heart failure

Gustavo Lopera, Agustín Castellanos, Eduardo De Marchena

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


Heart failure is a common and growing public health problem, with increasing incidence and prevalence over the last 2 decades. Despite improvements in its current management, heart failure is still associated with significant morbidity and mortality. This has motivated the search for newer therapeutic modalities, which are based on a better understanding on the pathophysiologic events that lead to heart failure. This review summarizes the potential role of new pharmacological agents in the treatment of heart failure. These potential new agents can be classified according to their role in the modulation of the main pathophysiologic abnormalities that characterized heart failure, that include: cellular-extracellular abnormalities, endothelial dysfunction, neurohormonal and immunologic activation.

Translated title of the contributionNew pharmacological agents in heart failure
Original languageSpanish
Pages (from-to)624-634
Number of pages11
JournalRevista Espanola de Cardiologia
Issue number5
StatePublished - May 2001


  • Heart failure
  • New pharmacological agents
  • Pathophysiology

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'New pharmacological agents in heart failure'. Together they form a unique fingerprint.

Cite this